(AMCR) Amcor - NYSE
Sector: Consumer Cyclical | Industry: Packaging & Containers | Exchange: NYSE (USA) | Market Cap: 18.993m USD | Total Return: -0.8% in 12m
Avg Turnover: 142M
EPS Trend: -78.4%
Qual. Beats: -1
Rev. Trend: 70.4%
Qual. Beats: 2
Warnings
Share dilution 59.8% YoY
Tailwinds
Tailwind, Pullback 52w
Amcor PLC is a global packaging manufacturer headquartered in Zurich, Switzerland, operating across Europe, North America, Latin America, and Asia Pacific. The company runs two main segments: Global Flexible Packaging Solutions, which produces polymer resin, aluminum, and fiber-based flexible packaging for food and beverage, medical and pharmaceutical, fresh produce, snack food, and personal care industries; and Global Rigid Packaging Solutions, which manufactures rigid containers, closures, dispensing systems, and pharmaceutical devices primarily for food and beverage applications.
Founded in 1926 and listed on the NYSE in 2019, Amcor sells its products primarily through a direct sales force. The packaging industry in which it operates is generally considered defensive, with demand closely tied to consumer staples and healthcare end markets rather than discretionary spending cycles.
Amcor is classified within the GICS Materials sector under the Metal, Glass & Plastic Containers sub-industry, reflecting its core focus on producing container and packaging components rather than raw materials extraction. As a large-cap issuer, it serves as one of the more established publicly traded packaging companies globally, supplying both consumer goods manufacturers and pharmaceutical companies.
- Berry Global merger integration drives cost synergies and revenue scale
- Resin and aluminum cost volatility pressures packaging segment margins
- EU sustainability regulation accelerates demand for recyclable flexible packaging
| Net Income: 779.0m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.02 > 0.02 and ΔFCF/TA -4.02 > 1.0 |
| NWC/Revenue: 13.31% < 20% (prev 20.52%; Δ -7.20% < -1%) |
| CFO/TA 0.04 > 3% & CFO 1.38b > Net Income 779.0m |
| Net Debt (15.1b) to EBITDA (3.04b): 4.97 < 3 |
| Current Ratio: 1.44 > 1.5 & < 3 |
| Outstanding Shares: last quarter (462.1m) vs 12m ago 59.79% < -2% |
| Gross Margin: 18.83% > 18% (prev 20.00%; Δ -1.18% > 0.5%) |
| Asset Turnover: 81.46% > 50% (prev 74.61%; Δ 6.84% > 0%) |
| Interest Coverage Ratio: 2.49 > 6 (EBIT TTM 1.60b / Interest Expense TTM 643.0m) |
| A: 0.08 (Total Current Assets 9.83b - Total Current Liabilities 6.81b) / Total Assets 37.6b |
| B: 0.01 (Retained Earnings 371.0m / Total Assets 37.6b) |
| C: 0.06 (EBIT TTM 1.60b / Avg Total Assets 27.8b) |
| D: 0.45 (Book Value of Equity 11.7b / Total Liabilities 25.9b) |
| Altman-Z'' = 1.42 = BB |
| DSRI: 1.06 (Receivables 3.51b/1.97b, Revenue 22.7b/13.5b) |
| GMI: 1.06 (GM 20.00% / 18.83%) |
| AQI: 1.30 (AQ_t 0.51 / AQ_t-1 0.39) |
| SGI: 1.68 (Revenue 22.7b / 13.5b) |
| TATA: -0.02 (NI 779.0m - CFO 1.38b) / TA 37.6b) |
| Beneish M = -2.25 (Cap -4..+1) = BBB |
As of June 28, 2026, the stock is trading at USD 43.03 with a total of 1,874,024 shares traded. Over the past week, the price has changed by +4.75%, over one month by +12.32%, over three months by +9.72% and over the past year by -0.77%.
Current recommended Stop Loss: 41.50 (which is 3.6% or 1.3 ATR below the current price).
Amcor has received a consensus analysts rating of 3.90. Therefore, it is recommended to buy AMCR.
- StrongBuy: 3
- Buy: 3
- Hold: 4
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 48.2 | 12% |
P/E Trailing = 32.864
P/E Forward = 10.2775
P/S = 0.8559
P/B = 1.6302
P/EG = 0.568
Revenue TTM = 22.7b USD
EBIT TTM = 1.60b USD
EBITDA TTM = 3.04b USD
Long Term Debt = 15.2b USD (from longTermDebt, last quarter)
Short Term Debt = 653.0m USD (from shortLongTermDebt, last quarter)
Debt = 16.7b USD (corrected: LT Debt 15.2b + ST Debt 653.0m) + Leases 853.0m
Net Debt = 15.1b USD (calculated: Debt 16.7b - CCE 1.59b)
Enterprise Value = 34.1b USD (19.0b + Debt 16.7b - CCE 1.59b)
Interest Coverage Ratio = 2.49 (Ebit TTM 1.60b / Interest Expense TTM 643.0m)
EV/FCF = 44.90x (Enterprise Value 34.1b / FCF TTM 759.8m)
FCF Yield = 2.23% (FCF TTM 759.8m / Enterprise Value 34.1b)
FCF Margin = 3.35% (FCF TTM 759.8m / Revenue TTM 22.7b)
Net Margin = 3.44% (Net Income TTM 779.0m / Revenue TTM 22.7b)
Gross Margin = 18.83% ((Revenue TTM 22.7b - Cost of Revenue TTM 18.4b) / Revenue TTM)
Gross Margin QoQ = 20.12% (prev 17.86%)
Tobins Q-Ratio = 0.91 (Enterprise Value 34.1b / Total Assets 37.6b)
Interest Expense / Debt = 3.85% (Interest Expense 643.0m / Debt 16.7b)
Taxrate = 8.80% (78.0m / 886.0m)
NOPAT = 1.46b (EBIT 1.60b * (1 - 8.80%))
Current Ratio = 1.44 (Total Current Assets 9.83b / Total Current Liabilities 6.81b)
Debt / Equity = 1.43 (Debt 16.7b / totalStockholderEquity, last quarter 11.7b)
Debt / EBITDA = 4.97 (Net Debt 15.1b / EBITDA 3.04b)
Debt / FCF = 19.90 (Net Debt 15.1b / FCF TTM 759.8m)
Total Stockholder Equity = 11.7b (last 4 quarters mean from totalStockholderEquity)
RoA = 2.80% (Net Income 779.0m / Total Assets 37.6b)
RoE = 6.67% (Net Income TTM 779.0m / Total Stockholder Equity 11.7b)
RoCE = 5.96% (EBIT 1.60b / Capital Employed (Equity 11.7b + L.T.Debt 15.2b))
RoIC = 4.89% (NOPAT 1.46b / Invested Capital 29.9b)
WACC = 5.64% (E(19.0b)/V(35.7b) * Re(7.52%) + D(16.7b)/V(35.7b) * Rd(3.85%) * (1-Tc(0.09)))
Discount Rate = 7.52% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: 89.89 | Cagr: 23.39%
[DCF] Terminal Value 73.10% ; FCFF base≈891.7m ; Y1≈782.0m ; Y5≈631.8m
[DCF] Fair Price = N/A (negative equity: EV 10.1b - Net Debt 15.1b = -4.98b; debt exceeds intrinsic value)
EPS Correlation: -78.40 | EPS CAGR: -8.86% | SUE: -1.24 | # QB: -1
Revenue Correlation: 70.35 | Revenue CAGR: 14.42% | SUE: 1.01 | # QB: 2
EPS next Quarter (2026-09-30): EPS=1.03 | Chg30d=-0.41% | Revisions=-43% | Analysts=7
EPS current Year (2026-06-30): EPS=3.98 | Chg30d=+0.00% | Revisions=+14% | GrowthEPS=+11.7% | GrowthRev=+54.0%
EPS next Year (2027-06-30): EPS=4.29 | Chg30d=-0.19% | Revisions=-33% | GrowthEPS=+7.8% | GrowthRev=+3.3%
[Analyst] Revisions Ratio: -43%